{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464200183
| IUPAC_name = (''RS'')-''N''-Carbamoyl-2-phenyl-butanamide
| image = Pheneturide.svg
| width = 175
| chirality = [[Racemic mixture]]

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|pheneturide}}
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 90-49-3
| ATC_prefix = N03
| ATC_suffix = AX13
| PubChem = 72060
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 65046
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 878CEJ4HGX
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01190

<!--Chemical data-->
| C=11 | H=14 | N=2 | O=2 
| molecular_weight = 206.241 g/mol
| smiles = O=C(N)NC(=O)C(c1ccccc1)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H14N2O2/c1-2-9(10(14)13-11(12)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H3,12,13,14,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AJOQSQHYDOFIOX-UHFFFAOYSA-N
}}

'''Pheneturide''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]) (brand names '''Benuride''', '''Deturid''', '''Pheneturid''', '''Septotence''', '''Trinuride'''),<ref name="Muller1998">{{cite book|author=Muller|title=European Drug Index: European Drug Registrations, Fourth Edition|url=https://books.google.com/books?id=HiSdvzs2pPAC&pg=PA998|date=19 June 1998|publisher=CRC Press|isbn=978-3-7692-2114-5|pages=998–}}</ref> also known as '''phenylethylacetylurea''' (or '''ethylphenacemide'''), is an [[anticonvulsant]] of the [[ureide]] class.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA959|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=959–}}</ref><ref name="pmid10423278">{{cite journal |author=Byrne B, Rothchild R |title=1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide |journal=Chirality |volume=11 |issue=7 |pages=529–35 |year=1999 |pmid=10423278 |doi=10.1002/(SICI)1520-636X(1999)11:7<529::AID-CHIR3>3.0.CO;2-K}}</ref> Conceptually, it can be formed in the body as a metabolic degradation product from <nowiki>[[phenobarbital]]</nowiki>. It is considered to be obsolete,<ref name="Levy2002">{{cite book|author=René H. Levy|title=Antiepileptic Drugs|url=https://books.google.com/books?id=HAOY0qG-vAYC&pg=PA210|year=2002|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-2321-3|pages=210–}}</ref> and is now seldom used.<ref name="Denham2012">{{cite book|author=M.J. Denham|title=The Treatment of Medical Problems in the Elderly|url=https://books.google.com/books?id=VFIBCAAAQBAJ&pg=PT335|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-6223-4|pages=335–}}</ref> It is marketed in [[Europe]], including in [[Poland]], [[Spain]], and the [[United Kingdom]].<ref name="Vida2013">{{cite book|author=Julius Vida|title=Anticonvulsants|url=https://books.google.com/books?id=u-qOecoMmqMC&pg=PA4|date=19 July 2013|publisher=Elsevier|isbn=978-0-323-14395-0|pages=4,42}}</ref> Pheneturide has a similar profile of anticonvulsant activity and toxicity relative to [[phenacemide]],<ref name="deStevensZingel2013">{{cite book|editor1-last=deStevens|editor1-first=G.|editor2-last=Zingel|editor2-first=V.|editor3-last=Leschke|editor3-first=C.|editor4-last=Hoeprich|editor4-first=P.D.|editor5-last=Schultz|editor5-first=R.M.|editor6-last=Mehrotra|editor6-first=P.K.|editor7-last=Batra|editor7-first=S.|editor8-last=Bhaduri|editor8-first=A.P.|editor9-last=Saxena|editor9-first=A.K.|editor10-last=Saxena|editor10-first=M.|title=Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques|date=11 November 2013|publisher=Birkhäuser|location=Basel|isbn=978-3-0348-7161-7|pages=217–|url=https://books.google.com/books?id=2mT0BwAAQBAJ&pg=PA217|accessdate=3 September 2016}}</ref> but is less toxic in comparison, despite still being a toxic drug.<ref name="Lancaster2013">{{cite book|author=Richard Lancaster|title=Pharmacology in Clinical Practice|url=https://books.google.com/books?id=tQ8lBQAAQBAJ&pg=PA222|date=22 October 2013|publisher=Elsevier|isbn=978-1-4831-9294-9|pages=222–}}</ref> As such, it is only used in cases of severe epilepsy when other, less-toxic drugs have failed.<ref name="Lancaster2013" /> Pheneturide inhibits the metabolism and thus increases the levels of other anticonvulsants, such as [[phenytoin]].<ref name="Denham2012" /><ref name="Vida2013" />

==See also==
* [[Phenacemide]]

==References==
{{Reflist|2}}

{{Anticonvulsants}}
{{Channel blockers}}

[[Category:Anticonvulsants]]
[[Category:Ureas]]

{{anticonvulsant-stub}}